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In the present investigation, 5-fluorouracil loaded microspheres of Eudragit 
(RS 100, RL 100 and RSPO) and ethylcellulose were prepared. “O/O solvent 
evaporation” technique was used for preparation of microspheres using 
(methanol + acetone)/liquid paraffin system. Magnesium stearate was used as 
the droplet stabilizer and n-hexane was added to harden the microspheres. The 
prepared microspheres were characterized for their micromeretic properties 
and entrapment efficiency; as well by Fourier transform infrared spectroscopy 
(FTIR) and thin layer chromatography (TLC). Photomicrographs were taken to 
study the shape of microspheres. The best fit release kinetics was achieved with 
Higuchi plot. Mean particle size, entrapment efficiency and production yields 
were highly influenced by the type of polymer and polymer concentration. 
It is concluded from the present investigation that various Eudragit and 
Ethylcellulose are promising controlled release carriers for 5-FU. 
KEY WORDS: 5-fluorouracil, Eudragit RS 100, Eudragit RL 100, Eudragit RSPO, 
Ethylcellulose, microspheres, solvent evaporation.
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RESUMEN
En la presente investigación, se han preparado microesferas de Eudragit (RS 
100, RL 100 y RSPO) y etilcelulosa cargadas con 5-fluorouracilo. Se ha utilizado 
la técnica de “evaporación del disolvente o/o” para preparar las microesferas 
utilizando el sistema de (metanol + acetona)/ parafina líquida. Se ha utilizado 
estearato de magnesio como estabilizador de gotículas y se ha añadido n-hexano 
para endurecer las microesferas. Las microesferas preparadas se caracterizan 
por sus propiedades micromeríticas y su eficaz compresión, así como a través 
de la espectroscopia infrarroja transformada de Fourier (FTIR, por sus siglas 
en inglés) y la cromatografía en capa fina. Se han tomado microfotografías 
para estudiar la forma de las microesferas. La mejor cinética de liberación se 
ha alcanzado con el modelo de Higuchi. El tamaño de la partícula principal, la 
eficacia de compresión y los rendimientos de producción han sido fuertemente 
influenciados por el tipo de polímero y su concentración. Tras la presente 
investigación, se ha determinado que el Eudragit y la Etilcelulosa tienen 
carreras muy prometedoras en la liberación controlada para el 5-FU 
PALABRAS CLAVE:  5-fluorouracilo, Eudragit RS 100, Eudragit RL 100, Eudragit 
RSPO, Etilcelulosa, microesferas, evaporación del disolvente.
INTRODUCCIÓN
5-Fluorouracil (5-FU) is an antimetabolite of the pyrimidine 
analog class which is widely used alone or in combination 
chemotherapy regimens. It interferes with nucleic acid 
synthesis, inhibits DNA synthesis, and eventually inhibits 
cell growth1. It has been the only agent with clinical 
activity against colorectal cancer. It is also used for 
malignancies, such as those of the breast, head and neck1. 
5-FU is poorly absorbed after oral administration with 
extremely variable bioavailability2. These disadvantages 
make it an appropriate candidate for microencapsulation. 
Microspheres are one of the multiparticulate delivery 
system and are prepared to obtain prolonged or controlled 
drug delivery to improve bioavailability or stability and 
to target drug to specific sites. Microspheres can also offer 
advantages like limiting fluctuation within therapeutic 
range, reducing side effects, decreasing dosing frequency 
and improving patient compliance3. Eudragit polymers are 
series of acrylate and methacrylate polymers available in 
different ionic forms. Eudragit RL 100, Eudragit RS 100 and 
Eudragit RSPO are insoluble in aqueous media but they 
are permeable and have pH-independent release profiles. 
The permeability of all the three polymers in aqueous 
media is due to the presence of quarternary ammonium 
groups in their structure; Eudragit RL 100 has a greater 
proportion of these groups and as such is more permeable 
than Eudragit RS 100 and Eudragit RSPO, while Eudragit 
RS 100 and Eudragit RSPO have same permeability due to 
their structural similarity. They differ in the physical forms 
where the previous has granular form and later has powder 
form. Ethylcellulose is an ethyl ether of cellulose, a long 
chain polymer consisting of anhydroglucose units joined 
together by acetal linkages. It is not metabolized following 
oral consumption and is therefore a noncaloric substance. 
It is generally regarded as a nontoxic, nonallergenic and 
nonirritant material. The main use of it in oral formulations 
is as a hydrophobic coating agent for tablets and granules. 
Release of a drug from its microcapsule is a function of 
capsule wall thickness. The aim of this study was to prepare 
Eudragit and ethylcellulose microspheres containing 5-FU 
to achieve a controlled drug release profile suitable for 
peroral administration. The microspheres were prepared 
by solvent evaporation technique using Eudragit and 
Ethylcellulose as a matrix polymer. (Methanol + acetone)/
Liquid paraffin system was used for the preparation 
of microspheres. Magnesium stearate was used as a 
droplet stabilizer to prevent droplet coalescence in the oil 
medium and n-hexane was added as a non-solvent to the 
processing medium to solidify the microspheres4. Firstly, 
we investigated formulation variables (polymer type and 
drug:polymer ratio) to obtain spherical particles. The 
effects of various Eudragit and Ethylcellulose on the yield 
of production, particle size distribution, encapsulation 
efficiency and 5-FU release rate from microspheres were 
investigated. The influences of formulation variables on 
the microsphere properties were examined. The prepared 
spherical microspheres were evaluated for micromeritic 
properties and drug content, and also by FTIR, TLC as well 
as for in vitro drug release studies4.
MATERIALS AND METHODS
Materials 
Eudragit RS 100, Eudragit RL 100 and Eudragit RSPO, 
Rohm Pharma; Ethylcellulose, S. D. Fine chem. Ltd; 
5-FU, Biochem; Magnesium sterate, Ottokemi; n-hexane, 
Spectrochem; Liquid paraffin Light, Central Drug House; 
Methanol, Central Drug House; Acetone, Central Drug 
House; Petroleum ether, Labort; Toluene, Merck; Other 
substances used were all of pharmaceutical grade.
Methods
Preparation of microspheres 
The technique used in preparation of microspheres was 
“O/O emulsion” solvent evaporation. As shown in table 1, 
three different formulations of each polymer (Eudragit RS 
100, Eudragit RL 100, Eudragit RSPO and Ethylcellulose) 
with drug (5-FU) in different drug:polymer ratios 1:1, 1:2, 
and 1:3 were prepared. The polymers were dissolved in 10 
ml of acetone separately. Pure 5-FU was dissolved in 13 ml 
of methanol. Both the solutions were mixed and 10 mg of 
Mg-stearate was dispersed in solution containing polymer 
and 5-FU. The dispersion was then stirred for 15 min. using 
magnetic stirrer.  The resultant dispersion was then poured 
into 500 ml beaker containing the external phase (135 ml 
liquid paraffin light + 15 ml n-hexane) with stirring. Three-
blade mechanical stirrer was used. Stirring (at 750 rpm) 
was continued for 4 hrs until acetone and methanol had 
evaporated completely. After evaporation of solvents, the 
microspheres formed were filtered using Whatman no. 41 
filter paper. The residue was washed 4-5 times in 25 ml 
n-hexane followed by 4-5 times in 50 ml petroleum ether 
(40˚C – 60˚C). Thereafter, the microspheres were dried in a 
desiccator for 24 h at room temperature. The microspheres 
were then stored in the desiccator4.
Production yield
The yield was calculated by dividing the weight of the 
collected microspheres by the weight of all the non-volatile 
components used for the preparation of microspheres and 
expressed in the terms of percentage5.
Percent Yield = (the amount of microspheres obtained/ 
the theoretical amount) x 100
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Tabla 1. Formulae for 5-FU loaded microspheres.
Formulation Drug (mg)
Significación clínica
Mg-stearate (mg) Curing  time (h)
RS100 RL100 RSPO EC
AS1 100 100 - - - 10 4
AS2 100 200 - - - 10 4
AS3 100 300 - - - 10 4
AL1 100 - 100 - - 10 4
AL2 100 - 200 - - 10 4
AL3 100 - 300 - - 10 4
AP1 100 - - 100 - 10 4
AP2 100 - - 200 - 10 4
AP3 100 - - 300 - 10 4
AE1 100 - - - 100 10 4
AE2 100 - - - 200 10 4
AE3 100 - - - 300 10 4
Particle size distribution analysis
Formulations of the microspheres were analyzed for particle 
size by optical microscope. The instrument was calibrated 
and found that 1unit of eyepiece micrometer was equal to 
7.5 µm. 300 microspheres’ sizes were calculated under 10 X 
magnification6.
Drug Entrapment efficiency (DEE)
Ten mg 5-FU loaded microparticles were dissolved in 100 
ml of PBS (pH 7.4) by shaking with magnetic stirrer for 24 
h. The solution was filtered through Whatman no. 41 filter 
paper. An aliquot was assayed spectrophotometrically 
(UV-1601 Schimadzu Corporation, Japan) for 5-FU at 266 
nm. Drug entrapment efficiency was determined by using 
the following relationship.
% Entrapment = (Actual content/ Theoretical content) x 
100
In vitro drug release study
The dissolution rate of 5-FU from the microspheres were 
studied using phosphate buffer solution (PBS) pH 7.4 
by paddle method (USP XXIII). Accurately weighed 
microspheres (equivalent to 10 mg of 5-FU) were taken 
for dissolution studies. The dissolution medium was 
kept at 37 ± 0.5˚C. Aliquots of sample were withdrawn 
at predetermined intervals of time and analyzed for drug 
release by measuring the absorbance at 266 nm. The volume 
withdrawn at each time intervals replaced with the same 
amount of fresh dissolution medium.
Release Kinetics
Data obtained from in vitro release studies were fitted to 
various kinetics equations to find out the mechanism of 
drug release from microsphers. The kinetic models used 
were Zero order, First order, Higuchi and Korsemeyer-
Peppas models. The rate constants were also calculated for 
the respective models4.
FTIR Study
Drug-polymer interactions were studied by FTIR 
spectroscopy. IR spectra for drug and drug loaded 
microspheres were recorded in a Fourier transform infrared 
(FTIR) spectrophotometer (FTIR-8400 S, Shimadzu, Japan) 
with KBr pellets. The scanning range was 400-4000 cm-1.
Thin Layer Chromatography (TLC)
Pure 5-FU and drug loaded microspheres were dissolved 
in methanol separately and about 10 µg samples were 
spotted on precoated silica gel G plate. The solvent used 
was methanol. The plates were developed for at least 10 
cm and then air dried. The Rf values were calculated and 
compared with the monographs7. 
Photomicrographs of microspheres
To study the shape of microspheres, photograph were 
taken using trinocular microscope (labomed, Olympus, 
CXRii) attached with camera.
RESULTS AND DISCUSSION
Mean particle size 
The effects of parameters like the type of polymer and 
polymer concentration on the production yield, entrapment 
efficiency, particle size distribution, in vitro drug release 
and drug polymer interaction were studied. 
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In the preparation methanol was used to dissolve the 
drug. As shown in table 2, the mean particle size for the 
formulations of Eudragit RS 100 was obtained in the range 
of 42.5 ± 3.387 µm to 44.3 ± 4.405 µm, for Eudragit RL 100 
it was 58.1 ± 1.345 µm to 80.1 ± 3.345 µm, for Eudragit 
RSPO, it was 99.5 ± 3.245 µm to 123.0 ± 8.479 µm and for 
Ethylcellulose it showed the range between 226.9 ± 5.214 
µm to 267.1 ± 3.857 µm.
Production Yield 
Production yields of the preparation for all the polymers 
and polymer concentrations were found to be very less. 
As shown in table 2, for Eudragit RS 100 the % yield was 
obtained in the range of 8.38 ± 0.652 to 21.45 ± 0.661, for 
Eudragit RL 100 it was 13.78 ± 0.833 % to 29.48 ± 0.883 %, 
for Eudragit RSPO it was 12.50 ± 1.176 % to 22.85 ± 2.553 % 
and for Ethylcellulose it showed the range 12.78 ± 0.937 % 
to 17.42 ± 1.889 %. 
Entrapment efficiency 
As shown in table 2, the entrapment efficiency was less 
for all formulations. As shown in table 2, for Eudragit RS 
100 the entrapment efficiency was obtained in the range of 
28.80 ± 2.405 % to 39.18 ± 2.660 %, for Eudragit RL 100 it 
was 22.36 ± 3.887 % to 35.63 ± 2.792 %, for Eudragit RSPO it 
was 28.45 ± 1.463 % to 40.63 ± 1.802 % and for Ethylcellulose 
and it showed in the range of 25.71 ± 2.785 % to 44.53 ± 
3.181 %.
The data revealed that particle size, entrapment efficiency, 
was highly influenced by type of polymer, polymer 
concentration and solvent used to dissolve the drug and 
polymer3,8-11. Methanol was used to dissolve the drug for 
all the formulations and it was found to be important factor 
to affect the production yield. The polymers were sticking 
to the vessel and the stirrer while evaporation of methanol, 
resulted in less production yield.
In Vitro Release Study
In vitro release studies of the formulations were carried out 
in the PBS (pH 7.4) at 37 ± 0.5 ˚C. As shown in fig 1, 2, 3 and 
4 the initial higher release of 5-FU from all the formulations 
was might have resulted from the dissolution of the drug 
crystals presented on the surface of the microspheres11. 
The formulations of Eudragit RS, AS1, AS2 and AS3 showed 
the complete drug release after 8, 9 and 11 h respectively 
as shown in figure 1. The formulations of Eudragit RL, 
AL1, AL2 and AL3 as shown in figure 2 were not able to 
sustain the drug release for 12 h and completely released 
after 5, 5, 8 h respectively. Release rates of 5-FU from 
Eudragit RL were faster than from Eudragit RS due to the 
fact, that the amount of quarternary ammonium groups of 
Eudragit RS is lower than that of Eudragit RL, therefore, 
Eudragit RL is more permeable to water, so that release 
was less retarded3. The formulations of Eudragit RSPO, 
AP1, AP2 and AP3 were also not able to sustain the drug 
release for 12 h and completely released after 9, 9 and 10 h 
respectively as shown in figure 3. The release of Eudragit 
RSPO microspheres was nearly same as that of Eudragit RS 
due to the same characteristics of both the polymers. 
As shown figure 4, formulations E1 and E2 were failed to 
sustain the drug release up to 12 h and showed complete 
release after 9 h and 10 h respectively. Formulation E3 was 
the only formulation showing about 97 % release after 12 
h, hence it was chosen as the optimized formulation. The 
dissolution data revealed that for all the formulations as 
Tabla 2. Percentage production yield, mean particle size and percentage entrapment efficiency of Formulations 
AS1-AE3
Formulations % yield * Mean Particle Size* (µm) % Entrapment Efficiency*
AS1 8.38 ± 0.652 42.5 ± 3.387 28.80 ± 2.405
AS2 14.47 ± 1.063 43.5 ± 1.100 33.09 ± 3.779
AS3 21.45 ± 0.661 44.3 ± 4.045 39.18 ± 2.660
AL1 13.78 ± 0.833 58.1 ± 1.345 22.36 ± 3.887
AL2 19.37 ± 0.682 72.6 ± 4.943 29.49 ± 2.842
AL3 29.48 ± 0.883 80.1 ± 3.345 35.63 ± 2.792
AP1 12.50 ± 1.176 99.5 ± 3.245 28.45 ± 1.463
AP2 17.15 ± 2.038 118.8 ± 2.179 34.98 ± 1.637
AP3 22.85 ± 2.553 123.0 ± 8.479 40.63 ± 1.802
AE1 12.78 ± 0.937 226.9 ± 5.214 25.71 ± 2.785
AE2 16.64 ± 1.678 247.7 ± 6.736 34.71 ± 2.979
AE3 17.42 ± 1.889 267.1 ± 3.857 44.53 ± 3.181
* indicates average of three readings ± SD
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Figure 3. In vitro release profile of 5-FU (n=3) from 
AP1, AP2 and AP3 formulations.
Figure 3. In vitro release profile of 5-FU (n=3) from 
AP1, AP2 and AP3 formulations.
Figure 1. In vitro release profile of 5-FU (n=3) from 
AS1, AS2 and AS3 formulations.
the polymer concentration was increased, the drug release 
rate decreased, depending on the drug-polymer ratio9.
Release Kinetics
The release kinetics of all the formulation was checked 
by fitting the release data to various kinetic models, and 
the release was best fitted to the Higuchi model. It was 
further confirmed by fitting the data to Korsmeyer-Peppas 
equation and the n value for all the formulations obtained 
between 0.2769 and 0.4399 revealed that the release was 
followed square root of time mechanism1. The R2 values 
for all the models are shown in table 3.
FTIR spectroscopy 
Drug polymer interaction was checked by the IR spectrum 
of the optimized formulations with the IR spectrum of 
pure drug. The IR spectrum of pure drug shows the 
characteristic peaks at 3124 cm-1 for NH stretching, 1716 
cm-1  and 1657 cm-1 for C=O stretching,  1245 cm-1 for CH 
in plane deformation and 813 cm-1 for CH out of plane 
deformation7. They were checked in the IR spectrum of 
optimized formulations. As shown in the Figure 5, Figure 
6 and Figure 7, there were no significant difference in the 
IR spectra of pure 5-FU and drug loaded formulations AS3 
and AE3.
TLC study
TLC of pure drug and that of formulations were carried 
out using methanol as solvent system on precoated silica 
gel plate. Iodine vapor was used for detection of spots. The 
Rf values for pure drug and the formulations are reported 
in table 4.
FTIR and TLC study suggested drug stability and no drug-
polymer interaction was occurred during the encapsulation 
process. Photomocrograph study revealed the sphere 
shape of microspheres.
Figure 2. In vitro release profile of 5-FU (n=3) from 
AL1, AL2 and AL3 formulations.
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Figure 5. FTIR 
Spectra of pure 
5-FU.
Tabla 3. Correlation coefficients of different mathematical models for 5-FU microspheres.
Sl. Formulations
Zero order First order Higuchi Korsemeyer Peppas
R2 R2 R2 n R2
1 AS1 0.8471 0.9342 0.9913 0.3634 0.9961
2 AS2 0.8755 0.9124 0.9941 0.3813 0.9968
3 AS3 0.8147 0.8867 0.9937 0.3642 0.9976
4 AL1 0.9823 0.9564 0.9931 0.2769 0.9886
5 AL2 0.9692 0.8714 0.9901 0.3893 0.9817
6 AL3 0.9472 0.9486 0.9910 0.3267 0.9912
7 AP1 0.8728 0.9291 0.9904 0.4399 0.9962
8 AP2 0.8364 0.8341 0.9868 0.3540 0.9951
9 AP3 0.8354 0.8352 0.9912 0.3826 0.9905
10 AE1 0.7620 0.9611 0.9882 0.3048 0.9943
11 AE2 0.7967 0.9768 0.9876 0.3161 0.9973
12 AE3 0.8186 0.9789 0.9933 0.3400 0.9971
Photomicrographs of microspheres
To study the shape of microspheres photograph were taken 
using trinocular microscope (labomed, Olympus, CXRii) 
attached with camera. Study revealed the spherical shape 
of the microspheres as shown in figure 8. 
CONCLUSION
5-FU microspheres were prepared easily and successfully 
using the solvent evaporation technique. The yield and 
entrapment efficiency were found to be very less for all 
the formulations prepared. Particle size obtained for the 
microspheres was less for all the formulations. Particle size, 
entrapment efficiency and production yield were found to 
be highly influenced by the type of polymer and polymer 
concentration. It was found that the release of drug from 
the formulations followed diffusion mechanism. The 
release kinetics of all the formulations was best fitted to the 
Higuchi model which revealed that the release followed 
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Figure 7. FTIR 
Spectra of 
Formulation AE3
Figure 6. FTIR 
Spectra of 
Formulation AS3
square root of time mechanism. According to the results 
of FTIR and TLC no drug interaction was occurred with 
polymer and 5-FU was found to be in crystal form in the 
prepared microspheres.
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